A phase 1 trial of APG-1387, an IAP antagonist, with nab-paclitaxel and gemcitabine in patients with refractory metastatic pancreatic cancerSi Shi, Xianjun Yu, Rujiao Liu et al.|Cell Reports Medicine|2025Cited by 1